Company Search:
Advanced Search
Sponsored Links
Generex Biotechnology Corporation Company Snapshot
Generex Biotechnology Corporation operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Generex Biotechnology with three other companies in this sector in UNITED STATES : Novabay Pharmaceuticals, Inc. (2019 sales of $6.60 million ), Cocrystal Pharma Inc ($6.56 million ), and Kala Pharmaceuticals Inc ($6.07 million of which 100% was Therapeutic).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Generex Biotechnology Corporation
  Stock Performance Chart for Generex Biotechnology Corporation
  Stock Data: Recent Stock Performance:
  Current Price (5/22/2020): .76
(Figures in U.S. Dollars)
1 Week 38.6%   13 Weeks 65.6%  
4 Weeks 22.2%   52 Weeks -25.0%  
Generex Biotechnology Corporation Key Data:
  Ticker: GNBT Country: United States
  Exchanges: FRA OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 6,203,761
(Year Ending Jan 2020).
Employees: 8
  Currency: U.S. Dollars Market Cap: 52,365,218
  Fiscal Yr Ends: July Shares Outstanding: 69,129,001
  Share Type: Common Closely Held Shares: 8,930,021
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.